Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y018512 | LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK227AC | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y008592 | SC / RA |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 4 | MM0530 | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z004454 | SC / LA |
All information provided in this narrative are per the patient's legal guardians report. Symptoms started on Saturday 5/1/26 - with patient exhibiting one "extremely watery" eye; on Sunday morning, 5/2/26, patient had a "runny clear nose and goopy yellow discharge eyes". Patient was seen by their primary care provider on Monday 5/4/26, who indicated to the patient's legal guardian that he thinks the patient was experiencing a reaction to the vaccines received on Wednesday 4/29/26. Dr. prescribed erythromycin 5 mg/gm ophthalmic ointment (commonly known as: ROMYCIN) and advised that future vaccines patient receives are spaced out and only one vaccine is administered at a time, rather than receiving multiple vaccines at once. As of the date of this report being submitted (Friday 5/8/26), the patient's legal guardian stated that the patient is doing "good and has mild symptoms".
None
None
Unknown
No known medication, food, or other allergies
None